Share market update: Nifty Pharma index flat; Sun Pharma rises 2%

Share market update: Nifty Pharma index flat; Sun Pharma rises 2% ... Shares of Sun Pharmaceutical Industries (up 2.59 per cent), Biocon (up 0.95 per cent), Glenmark Pharmaceuticals (up 0.73 per cent) and Cipla (up 0.21 per cent) were trading higher.

Tuesday, May 14, 2019

Related news

What spooked Sun Pharma stock in Monday's trade

Sun Pharma saw the steepest fall. While the knee-jerk reaction to the news was observed across pharma scrips, Sun Pharma nose-dived 20 per cent to hit a low of Rs 350.40, surprising many. A similar fall was observed in the shares of SPARC, which closed ...
Tuesday, May 14, 2019

Sun Pharmaceutical Industries' shares plunge 21% intra-day, recovers half

Shares of Sun Pharmaceutical Industries crashed 21.3 per cent on Monday in intra-day deals to a new year-low of ₹350.4 on the BSE but recovered a bit to end the at ₹396.85, down 9.4 per cent from Friday's close. Drop in the shares prices of prominent ...
Tuesday, May 14, 2019

Sell Sun Pharmaceutical Industries, target Rs 390: Dr CK Narayan

Dr CK Narayan of Chart Advise has a sell call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 390. The current market price of Sun Pharmaceutical Industries Ltd. is Rs 396.85. Time period given by the analyst is Intra Day when Sun ...
Tuesday, May 14, 2019

Sun Pharma Q3 results today: Here's what experts say

“We expect US revenue to grow 5 per cent QoQ and 10 per cent YoY in constant currency at $360 million, as market share gains Absorica, chlorthalidone and gInvega offset decline in gWelchol and Taro. Domestic sales expected to grow at 10 per cent YoY, ...
Wednesday, February 13, 2019

Sebi seeks answers on Sun Pharma's two issues

Earlier this month, Sun Pharma restructured some of its business operations to arrest its falling share price and allay investor concerns over corporate governance issues at the company. Among them were unwinding the company's domestic formulation ...
Wednesday, February 13, 2019

Sun Pharma Shares Jump After Company's Quarterly Profit Rises Nearly 4 Times

The Sun Pharma shares' price has declined 35 per cent over the past five months. As of 11 am, around 9.5 lakh Sun Pharma shares had changed hands on the Bombay Stock Exchange (BSE), compared with a two-week average of 5.6 lakh, stock exchange ...
Wednesday, February 13, 2019

Stocks in the news: IIFL Holdings, Sun Pharma, Axis Bank, Coal India and Bosch

IIFL Holdings: Promoters and key employees have bought shares of the company from the open market in the last one week. According to BSE data, Nirmal Jain, the chairman of the IIFL group, acquired 1 lakh shares of IIFL, while MD, K Ventaraman, and ...
Wednesday, February 13, 2019

Sun Pharma share price rises over 4% after four-fold rise in Q3 net profit

The Sun Pharmaceutical share price rose in early trade today after the firm logged nearly four-fold rise in its consolidated net profit at Rs 1,241.85 crore for the quarter ended on December 31, 2018 compared to Rs 321.57 crore net for the ...
Wednesday, February 13, 2019

Know 5 things before buying Sun Pharma shares

Its stock is valued at 3.4 times its consolidated revenues – while its peer Aurobindo Pharma is at 2.6 times, Lupin at 2.5, Cipla at 2.7 and Dr Reddy's and Cadila Healthcare at 3 times each. It's trading at 35 times its earnings versus the price-to ...
Monday, January 21, 2019

Stocks in the news: L&T, Sun Pharma, Kotak Mahindra Bank, Mindtree, Wipro and ...

Sun Pharma: The Sun Pharma stock has seen an additional short build-up Friday, after news emerged of the second whistleblower report being accessed by certain institutional investors. A day earlier news about the existence of a second whistle blower ...
Monday, January 21, 2019

सन फार्मा में पैसा लगाने का सही वक्त है?

पिछले दो महीनों में सन फार्मा के स्टॉक का दाम एक चौथाई गिर चुका है। कंपनी के स्टॉक में गिरावट उसके यहां कॉरपोरेट गवर्नेंस का कथित उल्लंघन होने को लेकर एक व्हिसलब्लोअर की तरफ से दर्ज कराई गई दो शिकायतों के बाद आई है। हालांकि, इस घटना का खुलासा होने के बाद भी बहुत से निवेशकों ने कंपनी के शेयर नहीं बेचे, इसलिए उन्हें बड़ा नुकसान उठाना पड़ा। अब बहुत से निवेशक ऐसे होंगे, जो मौजूदा लेवल पर कंपनी के स्टॉक्स को सस्ते दाम में खरीदने को तैयार नजर आ रहे होंगे। हालांकि, उनके लिए कंपनी के बारे में तस्वीर साफ होने तक का इंतजार करना बेहतर होगा। सन फार्मा के शेयर में पैसा लगाने से ...

Tanking shares and a new bout of questions plague Sun Pharma

Sun Pharmaceuticals' 12.7 per cent drop in share-price on Friday has raised a fresh bout of questions on activities surrounding India's largest drugmaker. The tanking share price, market-watchers said was linked to revelations last week of a second ...
Monday, January 21, 2019

Sun Pharma down nearly 40% since Oct, but experts say don't mistake it as a ...

Well, most technical experts feel that it is better to avoid catching the falling knife at current levels as the stock is in continuation of a downtrend and technically, there is no evidence of near-term bottom formation. Historical price behaviour of ...
Monday, January 21, 2019

Sun Pharma shares slump to six-year low on report of fresh allegations by ...

Shares of Sun Pharmaceutical Industries Ltd slumped over 13% today to near six-year low, after a media report of a complaint by a whistleblower raised fresh concerns on the drugmaker's corporate governance. The complaint, sent to the capital market ...
Friday, January 18, 2019

सन फार्मा / शेयर 13% गिरकर 6 साल के निचले स्तर पर, व्हिसलब्लोअर की शिकायत से जुड़ी रिपोर्ट का असर

मीडिया रिपोर्ट्स के मुताबिक व्हिसलब्लोअर ने कॉरपोरेट गवर्नेंस में गड़बड़ी की शिकायत की; रिपोर्ट का असर- कंपनी का शेयर 56 रु गिरकर 370.20 पर पहुंचा, यह फरवरी 2013 के बाद सबसे कम; बीएसई ने जवाब मांगा तो सन फार्मा ने कहा- ऐसी कोई शिकायत नहीं मिली. मुंबई. देश की सबसे बड़ी फार्मा कंपनी सन फार्मा का शेयर शुक्रवार को इंट्रा-डे में 13% गिरकर 6 साल के सबसे निचले स्तर पर पहुंच गया। कारोबार के दौरान एनएसई पर शेयर 56 रुपए टूटकर 370.20 रुपए पर आ गया। यह फरवरी 2013 के बाद सबसे कम भाव है। हालांकि, क्लोजिंग 8.51% गिरावट के साथ 390.25 रुपए पर हुई। मीडिया रिपोर्ट्स के मुताबिक व्हिसलब्लोअर ने सन ...

Sun Pharma Share Price Target: సన్ ఫార్మా షేరు ఢమాల్.. 6 ఏళ్ల కనిష్టానికి పతనం

ఫార్మా దిగ్గజం సన్ ఫార్మా షేరు శుక్రవారం భారీగా పతనమైంది. ఇంట్రాడేలో ఏకంగా 12 శాతానికి పైగా పడిపోయింది. దీంతో షేరు 6 ఏళ్ల కనిష్ట స్థాయికి క్షీణించింది. సన్ ‌ఫార్మా షేరు పడిపోవడంతో ఫార్మా ఇండెక్స్ కూడా పతనమైంది. సెన్సెక్స్‌లో ఇదే టాప్ లూజర్‌గా నిలిచింది. సన్ ఫార్మాతో పాటు యస్ బ్యాంక్, భారతీ ఎయిర్‌టెల్, హెచ్‌యూఎల్, యాక్సిస్ బ్యాంక్, ...
Friday, January 18, 2019

Sun Pharma shares plunge over 12% on whistleblower complaint

Mumbai: A whistleblower complaint of governance concerns led to a steep fall in the shares of Sun Pharmaceuticals Industries Ltd on Friday. Sun Pharma share prices plunged 12.12% to ₹375.4 during the day's trading, lowest since February 2013, before ...
Friday, January 18, 2019

Sun Pharma share price plunges more than 12% after whistleblower complaints ...

Sun Pharma share price today open at Rs 425.50 and soon tanked by more than 12% to Rs 370.20 apiece from the previous close on BSE. The tumble in shares comes after Moneylife opened up whistleblower documents for institutional investors.
Friday, January 18, 2019

Sun Pharma dives 12% on buzz over fresh whistleblower complaint; here's what ...

NEW DELHI: Shares of Sun Pharma crashed by falling over 12 per cent on Friday, taking their 2-day fall to 17 per cent. While there wasn't any ... Overall, the scrip has fallen 17.19 per cent over Wednesday's closing price of Rs 453.35. “Sun Pharma has ...
Friday, January 18, 2019

Stocks in the news: Sun Pharma, YES Bank, Uflex and Welspun Enterprises

Sun Pharma: India's largest drugmaker said that it will work towards re-establishing credibility and corporate governance which could include the review of some past decisions such as a $250 million loan to employees and others and a possible buyout of ...
Monday, December 3, 2018

Index trend and stocks in action December 04, 2018

Sun Pharmaceuticals: The company has clarified on the recent media reports that Sun Pharma has not been involved in any insider trading norm violations relating to the Ranbaxy deal. However, there was minor technical issue relating to procedural aspect ...

In Focus: Sun Pharma, Jet Airways, Prabhat Dairy, Laurus Labs and Maruti Suzuki

... largest data centre company by providing its infrastructure to global players like Microsoft and app makers, among others. 0Comments. Read more on. Sun Pharma share price · Jet Airways share price · Maruti Suzuki Share Price · Tata Motors Share Price.
Monday, December 3, 2018

Sun Pharma shares crash after whistleblower email to Sebi

The group used the infrastructure of brokerage firms to identify target companies and then started manipulating stock prices in direct or indirect ways, he alleged. Separately, the market regulator has taken cognizance of Australia-based investment ...
Monday, December 3, 2018

Sun Pharma plunges 9% on news Sebi may reopen insider trading case

Shares of Sun Pharma plunged 9 per cent in early trade on Monday on reports that markets regulator Sebi is likely to reopen an insider trading case against the company as well as probe alleged lapses by some of its promoters and other entities in ...
Monday, December 3, 2018